• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Organisation › Details

Cowen (Group)

Cowen Inc. is a diversified financial services firm and, together with its consolidated subsidiaries, provides alternative asset management, investment banking, research, sales and trading, prime brokerage, global clearing and commission management through its two business segments: Cowen Investment Management and its affiliates make up the Company’s alternative investment segment, while Cowen and Company, a member of FINRA and SIPC, and its affiliates make up the Company’s investment bank segment. Cowen Investment Management provides alternative asset management solutions to a global client base and manages a significant portion of Cowen’s proprietary capital. Cowen and Company and its affiliates offer industry focused investment banking for growth-oriented companies, domain knowledge-driven research, a sales and trading platform for institutional investors and a comprehensive suite of prime brokerage services. Founded in 1918, the firm is headquartered in New York and has offices worldwide. *

 

	Start	2012-06-10 existent
	Industry	finance
	Industry 2	investment banking
	Street	599 Lexington Avenue
	City	10022 New York, NY
	Tel	+1-646-562-1000
		Address record changed: 2012-06-10
Basic data	Employees	n. a.
		* Document for �About Section�: Allogene Therapeutics, Inc.. (6/18/18). "Press Release: Allogene Therapeutics Announces Eric T. Schmidt, Ph.D. as Chief Financial Officer". South San Francisco, CA & New York, NY.
		Record changed: 2018-12-30

Advertisement

More documents for Cowen (Group)

• [1] Argenx SE. (3/4/19). "Press Release: Argenx to Present at Cowen and Company 39th Annual Health Care Conference". Breda & Ghent....
• [2] Orchard Therapeutics Ltd.. (3/4/19). "Press Release: Orchard Therapeutics to Present at the Cowen 39th Annual Health Care Conference on March 11, 2019". Boston, MA & London....
• [3] Bruker Corporation. (2/25/19). "Press Release: Bruker Corporation to Present at Investor Conferences". Billerica, MA....
• [4] Cadent Therapeutics. (11/15/18). "Press Release: Cadent Therapeutics Secures $40 Million Series B Financing to Advance Pipeline of Novel Therapies for Movement and Cognitive Disorders". Cambridge, MA....
• [5] Kiadis Pharma N.V.. (3/14/18). "Press Release: Kiadis Pharma to Present at the Cowen and Company 38th Annual Health Care Conference". Amsterdam....
• [6] Hookipa Biotech AG. (3/7/18). "Press Release: Hookipa Biotech to Present at the Cowen and Company 38th Annual Healthcare Conference". Vienna....
• [7] Orchard Therapeutics Ltd.. (3/6/18). "Press Release: Orchard Therapeutics to Present at the Cowen and Company Annual Healthcare Conference". London....
• [8] Arsanis, Inc.. (3/5/18). "Press Release: Arsanis to Present at the 38th Annual Cowen and Company Health Care Conference". Waltham, MA & Vienna....
• [9] SpringWorks Therapeutics. (3/5/18). "Press Release: SpringWorks Therapeutics to Present at Cowen and Company’s 38th Annual Health Care Conference". New York, NY....
• [10] Argen-X N.V. (Argenx). (12/18/17). "Press Release: Argenx Announces Closing of U.S. Public Offering for Gross Proceeds of approximately $266 Million". Breda & Ghent....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Contact  |  The use of this website requires to accept the disclaimer!   |  A project of [iito] Business Intelligence © 2002-2019. Made in Germany.